Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biochemical Relapse-Free Survival in Postprostatectomy Patients Receiving 18F-Fluciclovine-Guided Prostate Bed-Only Radiation: Post Hoc Analysis of a Prospective Randomized Trial.
Dhere VR, Schuster DM, Goyal S, Schreibmann E, Hershatter BW, Patel SA, Shelton JW, Hanasoge S, Patel PR, Sebastian NT, Adediran OA, Lawal IO, Jani AB. Dhere VR, et al. Among authors: lawal io. Pract Radiat Oncol. 2024 Nov-Dec;14(6):e492-e499. doi: 10.1016/j.prro.2024.05.011. Epub 2024 Jul 20. Pract Radiat Oncol. 2024. PMID: 39032598 Clinical Trial.
Prospective investigation of amino acid transport and PSMA-targeted positron emission tomography for metastatic lobular breast carcinoma.
Mushtaq A, Lawal IO, Muzahir S, Friend SC, Bhave M, Meisel JL, Torres MA, Styblo TM, Graham CL, Kalinsky K, Switchenko J, Ulaner GA, Schuster DM. Mushtaq A, et al. Among authors: lawal io. Eur J Nucl Med Mol Imaging. 2024 Nov;51(13):4073-4082. doi: 10.1007/s00259-024-06830-7. Epub 2024 Jul 8. Eur J Nucl Med Mol Imaging. 2024. PMID: 38976035 Clinical Trial.
Advances in Radioligand Theranostics in Oncology.
Lawal IO, Abubakar SO, Ndlovu H, Mokoala KMG, More SS, Sathekge MM. Lawal IO, et al. Mol Diagn Ther. 2024 May;28(3):265-289. doi: 10.1007/s40291-024-00702-4. Epub 2024 Mar 31. Mol Diagn Ther. 2024. PMID: 38555542 Review.
Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study.
Sathekge MM, Lawal IO, Bal C, Bruchertseifer F, Ballal S, Cardaci G, Davis C, Eiber M, Hekimsoy T, Knoesen O, Kratochwil C, Lenzo NP, Mahapane J, Maserumule LC, Mdlophane AH, Mokoala KMG, Ndlovu H, Pant V, Rathke H, Reed J, Sen IB, Singh A, Sood A, Tauber R, Thakral P, Yadav MP, Morgenstern A. Sathekge MM, et al. Among authors: lawal io. Lancet Oncol. 2024 Feb;25(2):175-183. doi: 10.1016/S1470-2045(23)00638-1. Epub 2024 Jan 11. Lancet Oncol. 2024. PMID: 38218192
Integrated Genomic Analysis of Primary Prostate Tumor Foci and Corresponding Lymph Node Metastases Identifies Mutations and Pathways Associated with Metastasis.
Moreno CS, Winham CL, Alemozaffar M, Klein ER, Lawal IO, Abiodun-Ojo OA, Patil D, Barwick BG, Huang Y, Schuster DM, Sanda MG, Osunkoya AO. Moreno CS, et al. Among authors: lawal io. Cancers (Basel). 2023 Nov 30;15(23):5671. doi: 10.3390/cancers15235671. Cancers (Basel). 2023. PMID: 38067373 Free PMC article.
71 results